Compassionate use trials or expanded access trials

Expanded access refers to the administration of an investigational new medicine to patients for the diagnosis, observation, or treatment of a serious disease or condition outside of a clinical study. Contrarily, participants in clinical trials or studies—whether they are patients or healthy volunteers—are regarded as human subjects.

Expanded access may be necessary if all of the following hold true: Patient with a significant illness or condition, or whose illness or condition poses an imminent threat to their life. There is no alternative diagnosis method that is similar to or as effective

    Related Conference of Compassionate use trials or expanded access trials

    June 21-22, 2024

    52nd Global Nursing & Healthcare Conference

    Rome, Italy
    August 08-09, 2024

    20th World Congress on Healthcare & Technologies

    London, UK
    September 09-10, 2024

    3rd Global Summit on Physiology and Metabolism of Thyroid

    Paris, France
    September 18-19, 2024

    29th International Conference on Skincare and Cosmetology

    Amsterdam, Netherlands
    September 19-20, 2024

    20th Global Biomarkers and Clinical Research Summit

    Paris, France
    September 24-25, 2024

    5th Global Summit on Public Health

    Paris, France
    November 11-12, 2024

    9th Global Summit on Midwifery and Womens Health

    Dubai, UAE
    November 25-26, 2024

    10th World Holistic Nursing Conference

    Bali, Indonesia
    November 25-26, 2024

    4th International conference on Healthcare Summit

    Bali, Indonesia
    November 28-29, 2024

    World Vaccine Meet 2024

    Bali, Indonesia
    July 24-25, 2025

    36th European Heart and Heart Failure Congress

    Paris, France

    Compassionate use trials or expanded access trials Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in